Search by Drug Name or NDC
NDC 00703-5656-01 Toposar 20 mg/mL Details
Toposar 20 mg/mL
Toposar is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is ETOPOSIDE.
MedlinePlus Drug Summary
Etoposide injection is used in combination with other medications to treat cancer of the testicles that has not improved or that has worsened after treatment with other medications or radiation therapy. Etoposide injection is also used in combination with other medications to treat a certain type of lung cancer (small cell lung cancer; SCLC). Etoposide is in a class of medications known as podophyllotoxin derivatives. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 00703-5656-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Etoposide Injection
Product Information
NDC | 00703-5656 |
---|---|
Product ID | 0703-5656_57a9f2aa-e5c5-4bd2-856b-4ced775e2faa |
Associated GPIs | 21500010002030 |
GCN Sequence Number | 008841 |
GCN Sequence Number Description | etoposide VIAL 20 MG/ML INTRAVEN |
HIC3 | V1F |
HIC3 Description | ANTINEOPLASTICS,MISCELLANEOUS |
GCN | 07481 |
HICL Sequence Number | 003930 |
HICL Sequence Number Description | ETOPOSIDE |
Brand/Generic | Generic |
Proprietary Name | Toposar |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Etoposide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
Route | INTRAVENOUS |
Active Ingredient Strength | 20 |
Active Ingredient Units | mg/mL |
Substance Name | ETOPOSIDE |
Labeler Name | Teva Parenteral Medicines, Inc. |
Pharmaceutical Class | Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA074529 |
Listing Certified Through | n/a |
Package
NDC 00703-5656-01 (00703565601)
NDC Package Code | 0703-5656-01 |
---|---|
Billing NDC | 00703565601 |
Package | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5656-01) / 25 mL in 1 VIAL, MULTI-DOSE |
Marketing Start Date | 1996-08-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |